e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
From rare towards common lung diseases: diagnostic and monitoring challenges
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled nitric oxide (NO) – Proposed diagnostic criteria for pneumonias of various origins
N. Voskresenska, J. Voicehovska, G. Orlikov (Riga, Latvia)
Source:
Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Session:
From rare towards common lung diseases: diagnostic and monitoring challenges
Session type:
Thematic Poster Session
Number:
4621
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Voskresenska, J. Voicehovska, G. Orlikov (Riga, Latvia). Exhaled nitric oxide (NO) – Proposed diagnostic criteria for pneumonias of various origins. Eur Respir J 2010; 36: Suppl. 54, 4621
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Comparison of exhaled nitric oxide values measured by two offline methods or NO breath
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Exhaled nitric oxide reference values in healthy Tunisian adults
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Diagnosing asthma using exhaled nitric oxide (eNO) measurements
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003
Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Exhaled nitric oxide (NO) in patients with chronic cough
Source: Eur Respir J 2004; 24: Suppl. 48, 580s
Year: 2004
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Exhaled NO (FENO50) in COPD - Results from the TIE-study
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006
Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Diagnostic use of exhaled nitric oxide (eNO) after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 723s
Year: 2006
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Exhaled nitric oxide in asthma
Source: Eur Respir Monogr 2010; 49: 32-44
Year: 2010
Exhaled nitric oxide (NO) detection for monitoring airway inflammation in non-severe CAP
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Exhaled and nasal nitric oxide measurements: recommendations
Source: Guideline 1997
Year: 1997
Exhaled nitric oxide (eNO) for an epidemiological study in adults
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005
An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Increased exhaled nitric oxide levels predict uncontrolled asthma in children – Results from the MIDAS-study
Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept